Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Maarten O. van Aken
Effects of Therapy With [177Lu-DOTA0,Tyr3]octreotate on Endocrine Function
European Journal of Nuclear Medicine and Molecular Imaging
Medicine
Nuclear Medicine
Radiology
Imaging
Related publications
Neoadjuvant Treatment of Nonfunctioning Pancreatic Neuroendocrine Tumors With [177Lu-DOTA0,Tyr3]Octreotate
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
[177Lu]-Dota0-Tyr3-Octreotate: A Potential Targeted Radiotherapeutic for the Treatment of Medulloblastoma
Current Radiopharmaceuticals
Nuclear Medicine
Radiology
Imaging
Pharmacology
P2.12-03 Phase I/Ii Trial of 177Lu-Dota0-Tyr3-Octreotate (Lutathera) and Nivolumab for Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Nephrotoxicity After PRRT With 177Lu-Dota-Octreotate
European Journal of Nuclear Medicine and Molecular Imaging
Medicine
Nuclear Medicine
Radiology
Imaging
Rapid Kit-Based 68Ga-Labelling and PET Imaging With THP-Tyr3-octreotate: A Preliminary Comparison With DOTA-Tyr3-octreotate
EJNMMI Research
Nuclear Medicine
Radiology
Imaging
Predictors of Long-Term Outcome in Patients With Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy With 177Lu-Octreotate
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Adverse Effects of Adjuvant Endocrine Therapy
Medical Council
Potential Biomarkers for Radiation-Induced Renal Toxicity Following 177Lu-Octreotate Administration in Mice
PLoS ONE
Multidisciplinary
Salvage PRRT With 177Lu-Dota-Octreotate in Extensively Pretreated Patients With Metastatic Neuroendocrine Tumor (NET): Dosimetry, Toxicity, Efficacy, and Survival
BMC Cancer
Cancer Research
Oncology
Genetics
